Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jie Cui

Showing results (1061-1070 of 1,100) with videos related to

Pageof 110
Sort By:
Oncology Reports|November 6, 2014
In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell linesMin-Cong Wang, Xuan Liang, Zhi-Yan Liu, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2023
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003)Yuankai Shi, Jie Cui, Hui Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2025
Synergistic regulation of metal-organic cage architectures via temperature- and solvent-driven atropisomerismJiaqi Liang, Li-Jun Peng, Ke-Lin Zhu, et al.
The American Journal of Tropical Medicine and Hygiene|July 19, 2017
Analysis of Dengue Serotype 4 in Sri Lanka during the 2012-2013 Dengue EpidemicAnna Uehara, Hasitha Aravinda Tissera, Champica K Bodinayake, et al.
Scientific Reports|July 19, 2022
Latency period of PROM at term and the risk of neonatal infectious diseasesLu Zhuang, Zhan-Kui Li, Yuan-Fang Zhu, et al.
Journal for Immunotherapy of Cancer|April 10, 2026
Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trialHuangming Hong, Zegeng Chen, Jie Cui, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 14, 2017
Identification and Validation of Gene Expression Patterns in Cystitis Glandularis Patients and ControlsChen-Long Chu, Chen-Hui Zhao, Zhi-Wei Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
Acute to long-term characteristics of impedance recordings during neurostimulation in humansJie Cui, Filip Mivalt, Vladimir Sladky, et al.
BMC Pregnancy and Childbirth|July 5, 2022
Predicting risk of severe neonatal outcomes in preterm infants born from mother with prelabor rupture of membranesLu Zhuang, Zhan-Kui Li, Yuan-Fang Zhu, et al.
Elife|January 14, 2026
Fish CDK2 recruits Dtx4 to degrade TBK1 through ubiquitination in the antiviral responseLong-Feng Lu, Can Zhang, Zhuo-Cong Li, et al.
Pageof 110

Showing results (1061-1070 of 1,100) with videos related to

Sort By:
Pageof 110
Oncology Reports|November 6, 2014
In vitro synergistic antitumor efficacy of sequentially combined chemotherapy/icotinib in non‑small cell lung cancer cell linesMin-Cong Wang, Xuan Liang, Zhi-Yan Liu, et al.
Cancer Immunology, Immunotherapy : CII|June 8, 2023
Efficacy and safety of geptanolimab (GB226) for relapsed/refractory primary mediastinal large B-cell lymphoma: an open-label phase II study (Gxplore-003)Yuankai Shi, Jie Cui, Hui Zhou, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2025
Synergistic regulation of metal-organic cage architectures via temperature- and solvent-driven atropisomerismJiaqi Liang, Li-Jun Peng, Ke-Lin Zhu, et al.
The American Journal of Tropical Medicine and Hygiene|July 19, 2017
Analysis of Dengue Serotype 4 in Sri Lanka during the 2012-2013 Dengue EpidemicAnna Uehara, Hasitha Aravinda Tissera, Champica K Bodinayake, et al.
Scientific Reports|July 19, 2022
Latency period of PROM at term and the risk of neonatal infectious diseasesLu Zhuang, Zhan-Kui Li, Yuan-Fang Zhu, et al.
Journal for Immunotherapy of Cancer|April 10, 2026
Anti-TIM-3 antibody TQB2618 in combination with penpulimab in relapsed or refractory classic Hodgkin lymphoma previously treated with PD-1/PD-L1 therapy: a multicenter, open-label, single-arm, phase Ib clinical trialHuangming Hong, Zegeng Chen, Jie Cui, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 14, 2017
Identification and Validation of Gene Expression Patterns in Cystitis Glandularis Patients and ControlsChen-Long Chu, Chen-Hui Zhao, Zhi-Wei Zhang, et al.
Medrxiv : the Preprint Server for Health Sciences|February 12, 2024
Acute to long-term characteristics of impedance recordings during neurostimulation in humansJie Cui, Filip Mivalt, Vladimir Sladky, et al.
BMC Pregnancy and Childbirth|July 5, 2022
Predicting risk of severe neonatal outcomes in preterm infants born from mother with prelabor rupture of membranesLu Zhuang, Zhan-Kui Li, Yuan-Fang Zhu, et al.
Elife|January 14, 2026
Fish CDK2 recruits Dtx4 to degrade TBK1 through ubiquitination in the antiviral responseLong-Feng Lu, Can Zhang, Zhuo-Cong Li, et al.
Pageof 110